undamentalytics Newsletter
Sign in

Agilon Health, Inc. cash flow statement

In fiscal 2025, Agilon Health, Inc.'s operations generated −$106m of cash; it spent $13.2m on capital projects, leaving free cash flow of −$119m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−104−53−148−131−156−58−106−72
Depreciation and amortisation4114151420242928
Stock-based pay572922869514947
Capital spending3271516131313
Free cash flow−107−55−155−146−172−71−119−85
Free cash flow after stock pay−112−62−447−175−242−122−168−132
Share buybacks070020000—
Shares issued180341833121−3—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: AGL vs OPCHAGL vs ASTHAGL vs AMN

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Agilon Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Agilon Health, Inc.